Recommendations for new blood pressure treatments

A review by a major blood pressure collaboration conducted in 2005 helped inform the UK National Health Service, US Food and Drug Administration, European Society of Hypertension for new blood pressure treatment recommendations made by the National Collaborating Centre for Chronic Conditions and Royal College of Physicians guidelines for the management of type 2 diabetes. The US FDA also moved to change blood pressure drug pricing policy following this research, and the findings continue to be widely cited by the European Society of Hypertension guidelines.